Cargando…
Patient perceptions of anticoagulant treatment with dabigatran or a vitamin K antagonist for stroke prevention in atrial fibrillation according to region and age: an exploratory analysis from the RE-SONANCE study
BACKGROUND: The oral anticoagulant dabigatran offers an effective alternative to vitamin K antagonists (VKAs) for stroke prevention in atrial fibrillation (AF), yet patient preference data are limited. The prospective observational RE-SONANCE study demonstrated that patients with AF, newly initiated...
Autores principales: | Vinereanu, Dragos, Napalkov, Dmitry, Bergler-Klein, Jutta, Benczur, Bela, Ciernik, Martin, Gotcheva, Nina, Medvedchikov, Alexey, Põder, Pentti, Simić, Dragan, Skride, Andris, Tang, Wenbo, Trusz-Gluza, Maria, Vesely, Jiří |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605976/ https://www.ncbi.nlm.nih.gov/pubmed/33929686 http://dx.doi.org/10.1007/s11239-021-02450-2 |
Ejemplares similares
-
Patient perception of anticoagulant treatment for stroke prevention (RE-SONANCE study)
por: Vinereanu, Dragos, et al.
Publicado: (2020) -
Dabigatran Acylglucuronide, the Major Metabolite of Dabigatran, Shows a Weaker Anticoagulant Effect than Dabigatran
por: Kim, Jong-Min, et al.
Publicado: (2022) -
Neointima development in externally stented saphenous vein grafts. Progress in medicine is good for the patient: why not use total arterial revascularization?: Response to the Letter to the Editor: Neointima development in externally stented saphenous vein grafts. External stents are bad for the patient: why not use an undamaged saphenous vein for coronary artery bypass graft?
por: Krejca, Michał, et al.
Publicado: (2017) -
Promise and challenges of anticoagulation with dabigatran
por: Verma, Ashish, et al.
Publicado: (2012) -
Anticoagulant Related Nephropathy Induced by Dabigatran
por: Sharfuddin, Nazia, et al.
Publicado: (2018)